About Aphali Pharmaceuticals Limited
Data last updated:
Aphali Pharmaceuticals Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 16 October 1933 and has been in existence for over 93 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U27239MH1933PLC002027. Its GSTIN is 27AACCA6699Q1ZQ (Maharashtra).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹22.12 Lakh. It is led by directors including Shyam Hariwilas Kasat (Managing Director) and Seema Shyam Kasat.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.11 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net loss of ₹92,825 (net margin -0.8%) and EBITDA of -₹39,548 (EBITDA margin -0.4%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 6% over five years.
The company has about 17 employees on its provident fund (EPFO) records.
Court records list 16 cases involving the company, including 7 filed by the company and 8 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aphali.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address406 Auto Commerce House Near Kennedy Bridge Nana Chowk Grant R, Oad, Mumbai, Maharashtra, India – 400007
- IndustryHealthcare, Ayurvedic Products & Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Aphali Pharmaceuticals Limited
The main business activity of Aphali Pharmaceuticals is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Aphali Pharmaceuticals Limited FY 2025 filings available
Aphali Pharmaceuticals Limited reported revenue of ₹1.11 Cr (up 14% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Aphali Pharmaceuticals Limited
Revenue rose 14% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 6%. EBITDA fell 156% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Aphali Pharmaceuticals Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹39,548 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹92,825 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Aphali Pharmaceuticals Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -0.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Aphali Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Aphali Pharmaceuticals Limited
Aphali Pharmaceuticals Limited is compared with the companies closest to it by revenue in the Healthcare industry (Ayurvedic Products and Services, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Saudavel Pharmaceuticals Private Limited | ₹1.11 Cr (FY 2025) | •••• | •••• | -32.0% | •••• | Margao, Goa, India |
| Greendorse Health Products Private Limited | ₹1.11 Cr (FY 2024) | •••• | •••• | 141.0% | •••• | Haillymandi, Haryana, India |
| Rydan Pharmaceuticals Private Limited | ₹1.11 Cr (FY 2025) | •••• | •••• | 24.0% | •••• | Jaipur, Rajasthan, India |
| Sreeha Pharmaceuticals Private Limited | ₹1.11 Cr (FY 2021) | •••• | •••• | 752.0% | •••• | Hyderabad, Telangana, India |
| Avsan Pharmaceuticals Private Limited | ₹1.11 Cr (FY 2024) | •••• | •••• | 703.0% | •••• | Delhi, India |
| Aphali Pharmaceuticals Limited this company | ₹1.11 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Mumbai, Maharashtra, India |
| Celoris Pharmaceuticals Private Limited | ₹1.11 Cr (FY 2024) | •••• | •••• | 279.0% | •••• | Jalpaiguri, West Bengal, India |
| Khevo Pharmaceuticals Private Limited | ₹1.1 Cr (FY 2025) | •••• | •••• | 45.0% | •••• | Pune, Maharashtra, India |
| Swahaa Pharmaceuticals Private Limited | ₹1.1 Cr (FY 2025) | •••• | •••• | 80.0% | •••• | Delhi, India |
| Sarthanu Products Private Limited | ₹1.1 Cr (FY 2024) | •••• | •••• | 61.0% | •••• | Thane, Maharashtra, India |
| Ayurved Pratishthan (Nasik) Private Limited | ₹1.1 Cr (FY 2023) | •••• | •••• | -6.0% | •••• | Nashik, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Aphali Pharmaceuticals by revenue in the Healthcare industry (Ayurvedic Products and Services, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Aphali Pharmaceuticals Limited
Aphali Pharmaceuticals Limited is audited by DILIP GHOSE & CO for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| DILIP GHOSE & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Aphali Pharmaceuticals Limited
Aphali Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Seema Shyam Kasat Also directs: Farmak Private Limited | Director | 30 Jan 1996 | 30 Years 8 Months | Current |
| Aniruddha Shyamkumar Kasat | Director | 10 Mar 2016 | 10 Years 7 Months | Current |
| Shyam Hariwilas Kasat Also directs: Farmak Private Limited, Tarujyot Investments Limited | Managing Director | 24 Apr 1979 | 47 Years 5 Months | Current |
| Siddharth Shyamkumar Kasat Also directs: Tarujyot Investments Limited | Director | 10 Jul 2023 | 3 Years 3 Months | Current |
Ownership and Shareholding of Aphali Pharmaceuticals Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Aphali Pharmaceuticals Limited
Aphali Pharmaceuticals Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Aphali Pharmaceuticals Limited
Aphali Pharmaceuticals Limited has 16 court cases on record: 7 filed by Aphali Pharmaceuticals, 8 filed against it, 1 where it is another party. All cases are disposed. Status as checked between 28 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 9 | 4 | 0 |
| District courts | 7 | 4 | 0 |
Cases on record (5 of 16)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Civil suit | Filed against the company by Quality Cartons Private Limited | Disposed |
| Bombay High Court | Court case (CONP) | Filed against the company by A to Z Industrial Premises Co-Operative Society Ltd | Disposed |
| Bombay High Court | Company petition | Filed against the company by A to Z Industrial Premises Co-Operative Society Limited | Disposed |
| District court, Thane, Maharashtra | Court case (Civil M.A.) | Filed by the company against an individual | Disposed |
| District court, Thane, Maharashtra | Civil suit | Filed against the company by an individual | Disposed |
Full case history
All 16 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Aphali Pharmaceuticals Limited
Aphali Pharmaceuticals Limited has a workforce of 17 employees as of Apr 09, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Aphali Pharmaceuticals Limited
Aphali Pharmaceuticals Limited has 5 board changes on record since 1979: 4 appointments and 1 cessation. The latest: Siddharth Shyamkumar Kasat was appointed as Director on 10 Jul 2023.
Credit Ratings, Litigation & Regulatory Alerts for Aphali Pharmaceuticals Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Aphali Pharmaceuticals Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Aphali Pharmaceuticals Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Aphali Pharmaceuticals Limited
Aphali Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCA6699Q1ZQ | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Aphali Pharmaceuticals Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aphali Pharmaceuticals Limited
Aphali Pharmaceuticals is an active public limited company based in Mumbai, Maharashtra, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 16 October 1933 (93+ years old) and is registered under CIN U27239MH1933PLC002027.
Aphali Pharmaceuticals reported revenue of ₹1.11 Cr for FY 2025 (up 14% YoY).
Aphali Pharmaceuticals has 4 current directors:
- Shyam Hariwilas Kasat - Managing Director
- Seema Shyam Kasat - Director
- Aniruddha Shyamkumar Kasat - Director
- Siddharth Shyamkumar Kasat - Director
Aphali Pharmaceuticals reported a net loss of ₹92,825 (net margin -0.8%) and EBITDA of -₹39,548 (EBITDA margin -0.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Aphali Pharmaceuticals is 1% over three years and -6% over five years. In the latest year (FY 2025) revenue rose 14%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Aphali Pharmaceuticals is 27AACCA6699Q1ZQ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Aphali Pharmaceuticals is U27239MH1933PLC002027. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aphali Pharmaceuticals has 16 court cases on record: 7 filed by the company and 8 filed against it. Most are in the high courts.
Aphali Pharmaceuticals was incorporated on 16 October 1933, making it 93+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Aphali Pharmaceuticals by revenue are Saudavel Pharmaceuticals Private Limited, Greendorse Health Products Private Limited, Rydan Pharmaceuticals Private Limited, Sreeha Pharmaceuticals Private Limited, Avsan Pharmaceuticals Private Limited and 5 more, all in the Healthcare industry (Ayurvedic Products and Services, Pharmaceuticals).
Siddharth Shyamkumar Kasat was appointed as Director on 10 Jul 2023. Aniruddha Shyamkumar Kasat was appointed as Director on 10 Mar 2016. Siddharth Shyamkumar Kasat ceased to be Director on 10 Mar 2016. Aphali Pharmaceuticals has 5 board changes on record in total.